Skip to content

AtriCure ATRC Finished goods

Finished goods at other companies

Artivion logo
ArtivionAORT
$39.7M+27.4%
ITG
Integer HoldingsITGR
$23.36M+44.2%
Avanos Medical logo
Avanos MedicalAVNS
$78.2M+4.5%
Pacira BioSciences, Inc. logo
Pacira BioSciences, Inc.PCRX
$70.68M+27.2%
Medtronic logo
MedtronicMDT

Other financials

Income statement

See full
Revenue$141.2M+14.3%
Gross profit$109.3M+18.0%
Operating income$526.0K+109%
Net income$108.0K+102%
EPS (diluted)$0.00+100%

Balance sheet

See full
Cash & equivalents$146.2M+46.3%
Total debt$76.2M-3.1%
Total equity$491.7M+8.2%
Total assets$644.0M+8.8%

Cash flow

See full
Operating cash flow-$4.0M+63.8%
CapEx$3.9M+76.6%
Free cash flow-$7.8M+40.6%

Valuation

See full
Market cap$1.43B-7.9%
Enterprise value$1.36B-11.2%
P/S2.6×-0.6×

Profitability

See full
Gross margin75.6%+0.8pp
Operating margin-5.1%-1.3pp
Net margin-5.6%-1.5pp
FCF margin9.7%

Returns & leverage

See full
Return on equity-6.1%-1.3pp
Debt / equity0.2×0.0×
Current ratio4.3×+0.2×

Where this comes from

Reported directly by AtriCure in its filing.

Tagged under the XBRL concept us-gaap:InventoryFinishedGoodsNetOfReserves.

The official record: AtriCure’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about AtriCure's finished goods.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is AtriCure's finished goods?
AtriCure (ATRC) reported finished goods of $34.66M in Q1 2026.
How has AtriCure's finished goods changed year-over-year?
AtriCure's finished goods increased by 11.5% year-over-year, from $31.09M to $34.66M.
What is the long-term trend for AtriCure's finished goods?
Over 5 years (2020 to 2025), AtriCure's finished goods has grown at a 11.6% compound annual growth rate (CAGR), from $20.64M to $35.68M.
What does finished goods mean?
Completed products ready for sale, valued at the lower of cost or net realizable value.